DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹498 Cr |
| Mar2024 | ₹572 Cr |
| Mar2023 | ₹523 Cr |
| Mar2022 | ₹407 Cr |
| Mar2021 | ₹335 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹498 Cr | -12.94 | |
| Mar2024 | ₹572 Cr | 9.37 | |
| Mar2023 | ₹523 Cr | 28.52 | |
| Mar2022 | ₹407 Cr | 21.53 | |
| Mar2021 | ₹335 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,908.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
| MANKIND PHARMA | ₹82,039.3 Cr | -5.5% | -2% | -11.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2% |
-4.3% |
3.3% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses